Budesonide/Formoterol for Maintenance and Reliever Therapy Among Asthma Patients in Thailand
NCT00800241 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1020
Last updated 2010-12-03
Summary
The purpose of this study is to determine the incidence of misuse, i.e., over-use and under-use, of Budesonide/formoterol for maintenance and reliever therapy in usual-care setting.
Conditions
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Bandit Thinkhamrop, PhD. · Department of Biostatistics and Demography, Faculty of Public Health, Khon Kaen University
-
Watchara Boonsawat, MD, PhD · Department of Medicine, Faculty of Medicine, Khon Kaen University
Eligibility
- Min Age
- 12 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-05-31
- Completion
- 2009-11-30
Countries
- Thailand
Study Locations
More Related Trials
-
Fluticasone Furoate/GW642444 Inhalation Powder Long-Term Safety Study
NCT01018186 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Once-daily Budesonide/Formoterol Turbuhaler 4.5/160 µg in Step Down Asthma
NCT02725242 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Inhaled Mometasone/Formoterol Versus Inhaled Fluticasone/Salmeterol in Asthma Patients
NCT02415179 ·Status: COMPLETED ·Phase: NA
-
Study to Assess the Efficacy and Safety of Budesonide (PT008) in Adult Subjects With Mild to Moderate Persistent Asthma
NCT02105012 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment Efficacy of Budesonide/Formoterol in Cough Variant Asthma and Typical Asthma Patients
NCT02934945 ·Status: UNKNOWN ·Phase: PHASE4
-
Evaluation of the Effectiveness and Quality of Life With the Administration of the Fixed Combination of Budesonide Formoterol in Greek Patients With Asthma During Routine Clinical Practice.
NCT03033758 ·Status: COMPLETED
-
Evaluation of the Efficacy and Safety of a Fixed-dose, Single-capsule Budesonide-formoterol Combination in Uncontrolled Asthma
NCT01676987 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Investigate Real Life Effectiveness of Symbicort Maintenance and Reliever Therapy in Asthma Patients Across Asia
NCT00939341 ·Status: COMPLETED ·Phase: PHASE4
-
Quality of Life Assessment in Greek asthmatIc Patients Treated With the Fixed Dose Combination of Budesonide / Formoterol in Clinical Practice
NCT03055793 ·Status: COMPLETED
-
Randomized, Placebo-Controlled, Multidose, Study Comparing Generic Budesonide/Formoterol Fumarate Dihydrate to Symbicort® in Asthmatic Participants
NCT02495168 ·Status: COMPLETED ·Phase: PHASE3
-
Assessment of Airway Responsiveness and Treatment Efficacy in Asthmatics
NCT02574975 ·Status: UNKNOWN ·Phase: PHASE4
-
A 12-Week Study To Assess The Safety Of Fluticasone Propionate/Salmeterol 100/50 Hydrofluoroalkane (HFA) Versus Fluticasone Propionate 100 HFA In Children With Asthma
NCT00441441 ·Status: COMPLETED ·Phase: PHASE3
-
Utilization of Fixed Combination (Budesonide/Formoterol and Salmeterol/Fluticasone and Beclomethasone/Formoterol) in Treatment of Asthma Patients
NCT01327001 ·Status: COMPLETED
-
Evaluating the Efficacy and Safety of Fluticasone Furoate Inhalation Powder in the Treatment of Asthma in Adults and Adolescents
NCT01159912 ·Status: COMPLETED ·Phase: PHASE3
-
New Combination Inhaler (FlutiForm HFA MDI 100/10 µg and 250/10 µg) in Patients With Asthma
NCT00394121 ·Status: COMPLETED ·Phase: PHASE3
-
A 12-week Study to Assess the Efficacy and Safety of Budesonide and Formoterol Fumarate Metered Dose Inhaler Relative to Budesonide Metered Dose Inhaler in Participants With Inadequately Controlled Asthma (LITHOS)
NCT05755906 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety Study of Fluticasone Proponate Inhalation Solution in Adult and Adolescent Asthma
NCT01687283 ·Status: COMPLETED ·Phase: PHASE3
-
Study in Patients With Asthma
NCT00215410 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of FLUTIFORM ® vs Seretide® in Moderate to Severe Persistent Asthma in Subjects Aged ≥12 Years
NCT03387241 ·Status: UNKNOWN ·Phase: PHASE3
-
A 24-Week Efficacy and Safety Study to Assess Budesonide and Formoterol Fumarate Metered Dose Inhaler in Adult and Adolescent Participants With Inadequately Controlled Asthma (VATHOS)
NCT05202262 ·Status: COMPLETED ·Phase: PHASE3
-
The Efficacy of Budesonide/Formoterol in Cough Variant Asthma
NCT04171180 ·Status: UNKNOWN ·Phase: PHASE4
-
Safety and Tolerability of Ciclesonide and Formoterol Fumarate Inhaled Once Daily in Patients With Asthma (18 to 75 y) (BY9010/M1-506)
NCT00314509 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Efficacy and Long-Term Safety of Mometasone Furoate in Combination With Formoterol Fumarate Versus Mometasone Furoate in Children (5 to 11 Years of Age) With Persistent Asthma (MK-0887A-087)
NCT02741271 ·Status: COMPLETED ·Phase: PHASE3
-
Roflumilast Plus Montelukast in Adults With Severe Asthma
NCT01765192 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluating the Efficacy and Safety of Fluticasone Furoate in the Treatment of Asthma in Adults and Adolescents
NCT01431950 ·Status: COMPLETED ·Phase: PHASE3